bupranolol has been researched along with Psychophysiologic Disorders in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Psychophysiologic Disorders: A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988)
| Excerpt | Relevance | Reference |
|---|---|---|
| "52 patients with acute neurotic anxious and psychosomatic syndromes or chronic anxious and vegetative neuroses were treated orally with the combination drug Betamed (1 tablet contain 60 mg bupranolol and 2." | 5.05 | [Betamed in the treatment of psychogenic disorders with a somatic component]. ( Jellinger, K, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jellinger, K | 1 |
1 trial available for bupranolol and Psychophysiologic Disorders
| Article | Year |
|---|---|
[Betamed in the treatment of psychogenic disorders with a somatic component].
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupranolol; Clinical Trials as Topic; Diazepam; Drug Adm | 1983 |